This review summarizes the mechanisms, preoperative evaluation, and monitoring of hemostatic defects associated with cardiopulmonary bypass to manage postoperative bleeding.
Answers are grounded in this paper and cite their sources.
Wide post-CPB bleeding incidence variation warrants vigilant monitoring; leaves open standardization of hemostatic protocols.
Cardiac surgery requiring cardiopulmonary bypass (CPB) has increased in both number and safety over the past four decades. Postoperative bleeding continues to be a major cause of perioperative morbidity. The reported incidence varies from 4-32%. This paper reviews the preoperative evaluation and specific hemostasis defects associated with cardiac surgery and extracorporeal circulation. Monitoring of anticoagulation and coagulation, methods to decrease the alterations of the coagulation system, as well as the specific therapy for and risks of post-CPB bleeding are also discussed.
No takes yet. Share an insight, caveat, or question.
McCusker et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: